Ivan Oransky

1 month ago | cambridge.org | Ivan Oransky |Adam Marcus

Hostname: page-component-f554764f5-rvxtl Total loading time: 0 Render date: 2025-04-14T10:39:55.277Z Has data issue: false hasContentIssue false Published online by Cambridge University Press:  14 April 2025 Ivan Oransky [Opens in a new window]  and Show author details Keywords research misconductfraudinvestigationsuniversities Type Symposium Information Journal of Law, Medicine & Ethics , First View , pp.

1 month ago | medcentral.com | Marc E. Agronin |Ivan Oransky |Charles Piller |Greg Sackuvich

The oral NMDA receptor antagonist/sigma-1 receptor agonist AXS-05 significantly delayed and prevented Alzheimer’s disease agitation relapse compared with placebo, according to results of the ACCORD-2 trial presented at the 2025 American Academy of Neurology annual meeting held in San Diego this week. “These results support the use of AXS-05 as a safe and effective treatment for AD agitation,” said George Grossberg, MD, of Saint Louis University School of Medicine, St. Louis, MO.

2 months ago | inquisitivemag.org | Ivan Oransky |Adam Marcus

If you’re anything like us, when you take a pill, drive over a bridge, or make other important decisions, you want to know those choices are based on solid evidence.

Oct 1, 2024 | library.nd.edu | Ivan Oransky

Scientific Integrity and Retractions: A Talk By Ivan OranskyOctober 1, 202412:30 pm – 1:30 pmDr. Oransky will explore the complexities of scientific retractions, misconduct, and the importance of transparency in research. Drawing on his experience as co-founder of Retraction Watch and his work in scientific journalism, Dr. Oransky will discuss the hidden factors affecting scientific integrity and how the research community can promote accountability.

Sep 27, 2024 | tandfonline.com | Alison Abritis |Adam Marcus |Ivan Oransky

Advanced search Accountability in Research Ethics, Integrity and Policy Latest Articles Submit an article Journal homepage Full Article Figures & data References Citations Metrics Reprints & Permissions Read this article /doi/full/10.1080/08989621.2024.2404435?needAccess=true "The issue with special issues." Accountability in Research, ahead-of-print(ahead-of-print), pp. 1–2 Disclosure statement Alison Abritis, Adam Marcus, and Ivan Oransky are members of the Retraction Watch team. Additional...